Protective effect of 1-methylated β-carbolines against 3-morpholinosydnonimine-induced mitochondrial damage and cell viability loss in PC12 cells

Neurochemical Research

Volumn 29, Issue 10, 2004, Pages 1807-1816

  Tae Choi, Won ^a   Chul Youn, Young ^a   Sook Han, Eun ^a   Soo Lee, Chung ^a  

^a Chung Ang University   (South Korea)

Author keywords

1 methylated carbolines; Cell death; differentiated PC12 cells; mitochondrial membrane permeability; reactive nitrogen species

Indexed keywords

2 (4 CARBOXYPHENYL) 4,4,5,5 TETRAMETHYLIMIDAZOLINE 1 OXYL 3 OXIDE; ACETYLCYSTEINE; ANTIOXIDANT; BENZYLOXYCARBONYLASPARTYLGLUTAMYLMETHIONYLASPARTIC ACID; BENZYLOXYCARBONYLLEUCYLGLUTAMINYLHISTIDYLASPARTIC ACID; CARBOLINE DERIVATIVE; CARBONYL DERIVATIVE; CASPASE 3; CASPASE 9; CASPASE INHIBITOR; CYTOCHROME C; DITHIOTHREITOL; GLUTATHIONE; HARMALINE; HARMALOL; HARMINE; LINSIDOMINE; MELATONIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; URIC ACID;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DIFFERENTIATION; CELL LOSS; CELL STRAIN; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; MEMBRANE POTENTIAL; METHYLATION; MITOCHONDRIAL RESPIRATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN SECRETION; RAT;

ANIMALIA;

EID: 4644233834     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:NERE.0000042206.46554.e4     Document Type: Article

References (41)

1. Jenner, P. 2003. Oxidative stress in Parkinson's disease. Ann. Neurol. 53 (suppl 3):S26-S38.
2. Bernardi, P. 1996. The permeability transition pore. Control points of a cyclosporin A-sensitive mitochondrial channel involved in cell death. Biochim. Biophys. Acta 1275:5-9.
3. Mignotte, B. and Vayssière, J. L. 1998. Mitochondria and apoptosis. Eur. J. Biochem. 252:1-15.
4. Hunot, S., Boissiere, F., Faucheux, B., Brugg, B., Mouatt-Prigent, A., Agid, Y., and Hirsch, E. C. 1996. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease. Neuroscience 72:355-363.
5. Good, P. F., Hsu, A., Wener, P., Perl, D. P., and Olanow, C. W. 1998. Protein nitration in Parkinson's disease. J. Neuropathol. Exp. Neurol. 57:338-342.
6. Hantraye, P., Brouillet, E., Ferrante, R., Palfi, S., Dolan, R., Matthews, R. T., and Beal, M. F. 1996. Inhibition of neuronal nitric oxide synthase prevents MPTP-induced parkinsonism in baboons. Nat. Med. 2:1017-1021.
7. Brown, G. C. 1999. Nitric oxide and mitochondrial respiration. Biochim. Biophys. Acta 1411:351-369.
8. Poderoso, J. J., Carreras, M. C., Lisdero, C., Riobo, N., Schopfer, F., and Boveris, A. 1996. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondrial and submitochondrial particles. Arch. Biochem. Biophys. 328:85-92.
9. Ghafourifar, P., Schenk, U., Klein, S. D., and Richter, C. 1999. Mitochondrial nitric-oxide synthase stimulation causes cytochrome c release from isolated mitochondria. Evidence for intramitochondrial peroxynitrite formation. J. Biol. Chem. 274:31185-31188.
10. Albores, R., Neafsey, E. J., Drucker, G., Fields, J. Z., and Collins, M. A. 1990. Mitochondrial respiratory inhibition by N-methylated β-carboline derivatives structurally resembling N-methyl-4-phenylpyridine. Proc. Natl. Acad. Sci. USA 87:9368-9372.
11. Kuhn, W., Müller, T., Grosse, H., and Rommelspacher, H. 1996. Elevated levels of harman and norharman in cerebrospinal fluid of parkinsonian patients. J. Neural. Transm. 103:1435-1440.
12. +. Neurosci. Res. 44:255-265.
13. Kuhn, W., Müller, T., Grosse, H., and Rommelspacher, H. 1995. Plasma harman and norharman in Parkinson's disease. J. Neural. Transm. Suppl 46:291-295.
14. + in PC12 cells: insights into potential neurotoxicants in Parkinson's disease. J. Neurochem. 62:1503-1510.
15. O'Hearn, E. and Molliver, M. E. 1993. Degeneration of Purkinje cells in parasagittal zones of the cerebellar vermis after treatment with ibogaine or harmaline. Neuroscience 55:303-310.
16. Tse, S. Y. H., Mak, I. T., and Dickens, B. F. 1991. Antioxidative properties of harman and β-carboline alkaloids. Biochem. Pharmacol. 42:459-464.
17. Fuller, R., Wong, C. J., and Hemrick-Luecke, S. K. 1986. MD240928 and harmaline: opposite selectivity in antagonism of the inactivation of types A and B monoamine oxidase by pargyline in mice. Life Sci. 38:409-412.
18. Lee, C. S., Han, E. S., Jang, Y. Y., Han, J. H., Ha, H. W., and Kim, D. E. 2000. Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 Cells. J. Neurochem. 75:521-531.
19. Maher, P. and Davis, J. B. 1996. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16:6394-6401.
20. Kim, D. H., Jang, Y. Y., Han, E. S., and Lee, C. S. 2001. Protective effect of harmaline and harmalol against dopamine- and 6-hydroxydopamine-induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells. Eur. J. Neurosci. 13:1861-1872.
21. Tatton, W. G., Chalmers-Redman, R. M. E., Ju, W. J. H., Mammen, M., Carlile, G. W., Pong, A. W., and Tatton, N. A. 2002. Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J. Pharmacol. Exp. Ther. 301:753-764.
22. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
23. Oberhammer, F. A., Pavelka, M., Sharma, S., Tiefenbacher, R., Purchio, A. F., Bursch, W., and Schulte-Hermann, R. 1992. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor β1. Proc. Natl. Acad. Sci. USA 89:5408-5412.
24. Isenberg, J. S. and Klaunig, J. E. 2000. Role of the mitochondrial membrane permeability transition (MPT) in rotenone-induced apoptosis in liver cells. Toxicol. Sci. 53:340-351.
25. Lizard, G., Miguet, C., Bessede, G., Monier, S., Gueldry, S., Neel, D., and Gambert, P. 2000. Impairment with various antioxidants of the loss of mitochondrial transmembrane potential and of the cytosolic release of cytochrome c occurring during 7-ketocholesterol-induced apoptosis. Free Radic. Biol. Med. 28:743-753.
26. Fu, W., Luo, H., Parthasarathy, S., and Mattson, M. P. 1998. Catecholamines potentiate amyloid β-peptide neurotoxicity: involvement of oxidative stress, mitochondrial dysfunction, and perturbed calcium homeostasis. Neurobiol. Dis. 5:229-243.
27. van Klaveren, R. J., Hoet, P. H., Pype, J. L., Demedts, M., and Nemery, B. 1997. Increase in gamma-glutamyltransferase by glutathione depletion in rat type II pneumocytes. Free Radic. Biol. Med. 22:525-534.
28. Kaur, H., Whiteman, M., and Halliwell, B. 1997. Peroxynitrite-dependent aromatic hydroxylation and nitration of salicylate and phenylalanine. Is hydroxyl radical involved? Free Radic. Res. 26:71-82.
29. 2+-ATPase inactivation induced by peroxynitrite. Biochim. Biophys. Acta 1523:189-195.
30. Gutteridge, J. M. C., Rowley, D. A., and Halliwell, B. 1982. Superoxide dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of 'catalytic' iron and anti-oxidant activity in extracellular fluids. Biochem. J. 201:605-609.
31. Levine, R. L., Garland, D., Oliver, C. N., Amid, A., Climent, I., Lenz, A. G., Ahn, B. W., Shaltiel, S., and Stadman, E. R. 1990. Determination of carbonyl content in oxidatively modified proteins. Oxygen radicals in biological systems. Methods Enzymol. 186:464-478.
32. Jurma, O. P., Horn, D. G., and Andersen, J. K. 1997. Decreased glutathione results in calcium-mediated cell death in PC12. Free Radic. Biol. Med. 23:1055-1066.
33. Kadota, T., Yamaai, T., Saito, Y., Akita, Y., Kawashima, S., Moroi, K., Inagaki, N., and Kadota, K. 1996. Expression of dopamine transporter at the tips of growing neurites of PC12 cells. J. Histochem. Cytochem. 44:989-996.
34. Chandra, J., Samali, A., and Orrenius, S. 2000. Triggering and modulation of apoptosis by oxidative stress. Free Radic. Biol. Med. 29:323-333.
35. Bal-Price, A. and Brown, G. C. 2000. Nitric-oxide-induced necrosis and apoptosis in PC12 cells mediated by mitochondria. J. Neurochem. 75:1455-1464.
36. Stewart, V. C. and Heales, S. J. R. 2003. Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration. Free Radic. Biol. Med. 34:287-303.
37. + analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease. Neurology 45:2240-2245.
38. Matsubara, K., Gonda, T., Sawada, H., Uezono, T., Kobayashi, Y., Kawamura, T., Ohtaki, K., Kimura, K., and Akaike, A. 1998. Endogenously occurring β-carboline induces parkinsonism in nonprimate animals: a possible causative protoxin in idiopathic Parkinson's disease. J. Neurochem. 70:727-735.
39. Birkmayer, W., Knoll, J., Riederer, P., Youdim, M. B., Hars, V., and Marton, J. 1985. Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study. J. Neural. Transm. 64:113-127.
40. Tatton, W. G. and Chalmers-Redman, R. M. 1996. Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration. Neurology 47:8171-5183.
41. Jacobsson, S. O. and Fowler, C. J. 1999. Dopamine and glutamate neurotoxicity in cultured chick telencephali cells: effects of NMDA antagonists, antioxidants and MAO inhibitors. Neurochem. Int. 34:49-62.